Acrux Stock

Acrux Dividend

Dividend of Acrux (ACR.AX) as of Jul 15, 2026.

Dividend

0.00AUD

Dividend yield

745.34 %

Last updated:

How much dividend does Acrux 2026 pay?

According to the latest status from July 2026, Acrux paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current Acrux price of 0.01 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 745.34%. The payout ratio is around 155% of earnings.

Historical Acrux Dividends

PaydateDividend
9/18/20150.09AUD
10/4/20140.11AUD
3/25/20140.12AUD
10/3/20130.08AUD
10/4/20120.08AUD
5/1/20110.60AUD

Is the Acrux Dividend Safe?

Acrux has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Acrux dividend payout ratio

In 2025, Acrux had a payout ratio of 143.50%. The payout ratio indicates the percentage of the company's profits that Acrux distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
142.55 %
Jan 1, 2021
143.24 %
Jan 1, 2022
143.85 %
Jan 1, 2023
143.21 %
Jan 1, 2024
143.43 %
Jan 1, 2025
143.50 %
Jan 1, 2026 (e)
472.79 %
Jan 1, 2027 (e)
953.55 %

Dividend Details

Understanding Acrux's Dividend Distributions

Acrux’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Acrux's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Acrux's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Acrux’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Acrux Stock analysis

What does Acrux do? Acrux Ltd is an Australian pharmaceutical company specializing in the development and marketing of products in the dermatology field. The company was founded in 1998 and is headquartered in Melbourne. Its history begins with the development of a groundbreaking technology called the "Sprayform® Technology," which allows the administration of liquid medications in spray form, providing numerous advantages compared to traditional administration methods. Acrux obtained the first patent for this technology in 1999 and worked on bringing it to the market. Its business model focuses on licensing its Sprayform® Technology to third parties to advance the development and marketing of products in various therapeutic areas. The company has an experienced research and development team that collaborates closely with partners to develop tailored solutions and support the entire development process, ensuring that all products meet the highest quality standards and regulatory requirements. Acrux Ltd is divided into various divisions, including products for women, diabetes, pain and inflammation, as well as neurology and psychiatry. With its Sprayform® Technology, the company has developed unique therapeutic solutions that meet patients' needs. For example, a testosterone preparation for women has been developed that is simply applied as a spray and offers higher efficacy than traditional tablets. Another product is a fast-acting pain reliever that is administered through a nasal spray. Acrux Ltd also has partnerships with major pharmaceutical companies such as Eli Lilly, Johnson & Johnson, Pfizer, and Sanofi. These partnerships enable Acrux to market its technology globally and offer its customers a comprehensive portfolio of tailored solutions. The partner is granted exclusive rights to use the technology for specific products and markets, facilitating the development of new products and the expansion into new regions. Overall, Acrux Ltd has achieved a leadership position in the field of transdermal systems and transmucosal technologies through its innovative Sprayform® Technology. The company aims to further expand its leadership position by focusing on the development of new products and collaboration with partners. Acrux remains in constant exchange with the scientific community to incorporate the latest research and development insights into its products. Acrux is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acrux stock

Over the past 12 months, Acrux paid a dividend of 0.09 AUD . This corresponds to a dividend yield of about 745.34 %. For the coming 12 months, Acrux is expected to pay a dividend of 0.17 AUD.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Acrux